関連する実験動画

Updated: Aug 4, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K

TMS治療前のラモトリギン中止の是非：3症例報告

Xia Li1, Ethan Li1, Cory Weissman1

  • 1Department of Psychiatry, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
|February 20, 2026
PubMed
まとめ

No abstract available in PubMed .

さらに関連する動画

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

570
Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder11:17

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

475

関連する概念動画

Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.